Skip to content

Insider · CIK 0001620013

Donald Allen Williams

director

Files at PALI (PALISADE BIO, INC.). First filing Oct 5, 2026, latest Oct 5, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$29k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PALI: PALISADE BIO, INC.

PALIOct 9, 2026 · close 1.54

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
PALIbuy
PALISADE BIO, INC.
$29k
20,000 shares
+1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026PALI
PALISADE BIO, INC.
POpen-market purchase
Common Stock
+10,000$1.42$14k1,580,2947 d ago
Oct 2, 2026PALI
PALISADE BIO, INC.
POpen-market purchase
Common Stock
+10,000$1.46$15k1,590,2947 d ago
Oct 6, 2025PALI
PALISADE BIO, INC.
AGrant or award
Restricted Stock Unitsderivative
+182,000$0.00$0182,000Nov 6, 2025
Oct 6, 2025PALI
PALISADE BIO, INC.
AGrant or award
Restricted Stock Unitsderivative
+1,538,700$0.00$01,538,700Oct 8, 2025
Sep 4, 2025PALI
PALISADE BIO, INC.
AGrant or award
Phantom Unitsderivative
+64,400$0.00$064,400Sep 5, 2025
Nov 21, 2024PALI
PALISADE BIO, INC.
MOption exercise
Comon Stock, par value $0.01
+388$0.00$0728Nov 22, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Donald Allen Williams: insider trades and track record | InsiderTell